BHARAT IMMUNOLOGICALS EBITDA

BHARAT IMMUNOLOGICALS ebitda fundamental analysis lookup allows you to check this and other indicators for BHARAT IMMUNOLOGICALS BIOLOG or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

BHARAT IMMUNOLOGICALS EBITDA Analysis

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis
BHARAT IMMUNOLOGICALS EBITDA  =
(87.87 M)
BHARAT IMMUNOLOGICALS ValuationFundamentalsBuy or Sell

About EBITDA

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.Compare to competition
According to company disclosure BHARAT IMMUNOLOGICALS BIOLOG reported loss before interest,tax, depreciation and amortization of -8.787E7. This is 110.01% lower than that of the Healthcare sector, and 187.73% lower than that of Biotechnology industry, The EBITDA for all stocks is 102.25% higher than the company.

Did you try this?

Run Analyst Recommendations Now

   

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

BHARAT IMMUNOLOGICALS current financial ratios



 
Search macroaxis.com